Letter to the editor: FDA report a disservice to fibroids patients
|
Thirty-six signees suggest that the FDA did not completely examine the evidence for risks and benefits to women undergoing surgery for suspected fibroids. They recommend that Contemporary OB/GYN readers also review the AHRQ findings on morcellation and decide which report serves patients better. |
More
|